This is a firm-fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Promega Corporation for 100,000 units of the ADP-GLO Kinase Assay (Promega Product #V9103) with a potential value of $17,990.25. The contract has a performance period running through September 30, 2024. Promega is a global life sciences company that provides DNA analysis equipment, reagents, assays, and related laboratory supplies to support biomedical research and testing programs across federal agencies. The award is not associated with a set-aside program. Promega currently holds two active blanket purchase agreements with the NIH and Defense Health Agency for biological materials, chemicals, medical equipment, and DNA analysis systems.
Generated 4/12/24, 10:08 AM